This analysis demonstrates the role of cell size imaging and magnetization transfer imaging in forecasting disease outcomes in patients with Crohn’s disease.
Motivation: Intestinal fibrosis assessment by simultaneously characterizing mesenchymal cells and extracellular collagen may help predict disease progression in patients with Crohn's disease (CD). Goal(s): To evaluate the efficacy of time-dependent diffusion MRI (TD-dMRI) in characterizing cellular properties, and combine it with magnetization transfer (MT)-MRI to depict intestinal fibrosis and predict disease progression. Approach: 124 CD patients (31 received surgery) were prospectively enrolled and underwent TD-dMRI to map fibrotic microstructures and MT-MRI to quantify collagen levels. 93 nonsurgical patients were followed up. Results: TD-dMRI-derived cell diameter (d) was highly correlated with myofibroblasts/fibroblasts-area-ratio (r=0.58; P<0.001). d was significant risk factor for disease progression (HR: 1.2; P=0.001). Impact: TD-dMRI-derived d effectively characterizes fibrosis-associated cellular microstructures in patients with CD, and combined with normalized MT ratio enables a comprehensive assessment of intestinal fibrosis and thus accurate prediction of disease progression.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: